Cargando…
Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
Autores principales: | Du, Wei, Yi, Yong, Zhang, Haibo, Bergholz, Johann, Wu, Junfeng, Ying, Haoqiang, Zhang, Yujun, Xiao, Zhi-Xiong Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866301/ http://dx.doi.org/10.1371/annotation/f1a4d192-57b9-43fb-a248-379e0f5a46ca |
Ejemplares similares
-
Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013) -
Correction: p63α modulates c-Myc activity via direct interaction and regulation of MM1 protein stability
por: Han, Anning, et al.
Publicado: (2017) -
Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
por: Sahin, Ilyas, et al.
Publicado: (2020) -
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022) -
Correction to: Central IGF1 improves glucose tolerance and insulin sensitivity in mice
por: Hong, Hao, et al.
Publicado: (2021)